Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 63Carcinoma, Non-Small-Cell Lung 60Rectal Neoplasms 44Glioblastoma 42Stomach Neoplasms 37Esophageal Neoplasms 33Brain Neoplasms 33Squamous Cell Carcinoma of Head and Neck 31Colorectal Neoplasms 29Pancreatic Neoplasms 26Lung Neoplasms 24Neoplasms 23Glioma 23Astrocytoma 22Neoplasm Metastasis 21Head and Neck Neoplasms 19Sarcoma 17Gliosarcoma 15Esophageal Squamous Cell Carcinoma 15Central Nervous System Neoplasms 15Ovarian Neoplasms 14Oligodendroglioma 13Melanoma 13Colonic Neoplasms 12Adenocarcinoma Of Esophagus 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11Carcinoma, Hepatocellular 11Oropharyngeal Neoplasms 9Carcinoma, Ovarian Epithelial 9

Interventions

Cabergoline 5Dopamine Agonists 2ropinirole 1pasireotide 1Temozolomide 1Surgical Procedures, Operative 1Standard of Care 1Microarray Analysis 1Lapatinib 1Early Intervention, Educational 1Dexamethasone 1DNA Methylation 1Clomiphene 1Calcium Dobesilate 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Prolactinoma × Surgical Procedures, Operative × Clear all
NCT03717454 2018-11-20

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Ruijin Hospital

Phase NA Unknown
50 enrolled

Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡